MG
Meditor Group’s Celldex Therapeutics CLDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-196,846
| Closed | -$2.56M | – | 6 |
|
|
2020
Q2 | $2.56M | Sell |
196,846
-224,000
| -53% | -$2.91M | 0.54% | 6 |
|
|
2020
Q1 | $563K | Hold |
420,846
| – | – | 0.19% | 6 |
|
|
2019
Q4 | $708K | Hold |
420,846
| – | – | 0.2% | 6 |
|
|
2019
Q3 | $896K | Hold |
420,846
| – | – | 0.22% | 9 |
|
|
2019
Q2 | $1.13M | Hold |
420,846
| – | – | 0.23% | 9 |
|
|
2019
Q1 | $2.07M | Sell |
420,846
-5,891,854
| -93% | -$29M | 0.39% | 9 |
|
|
2018
Q4 | $1.25M | Hold |
6,312,700
| – | – | 0.26% | 6 |
|
|
2018
Q3 | $2.85M | Hold |
6,312,700
| – | – | 0.61% | 6 |
|
|
2018
Q2 | $3.18M | Hold |
6,312,700
| – | – | 0.62% | 6 |
|
|
2018
Q1 | $14.7M | Hold |
6,312,700
| – | – | 2.31% | 4 |
|
|
2017
Q4 | $17.9M | Hold |
6,312,700
| – | – | 2.31% | 4 |
|
|
2017
Q3 | $18.1M | Buy |
6,312,700
+512,700
| +9% | +$1.47M | 2.74% | 4 |
|
|
2017
Q2 | $14.3M | Buy |
5,800,000
+1,654,100
| +40% | +$4.09M | 2.16% | 8 |
|
|
2017
Q1 | $15M | Buy |
+4,145,900
| New | +$15M | 2.68% | 7 |
|